patent

News

Biogen bonus as generic Tecfidera approvals are pulled in EU

The European Commission has pulled marketing authorisations for generic versions of Biogen’s oral multiple sclerosis therapy Tecfidera, after concluding that the brand qua

Sales & Marketing

All eyes remain on US government patent dispute with Gilead

A high-stakes court battle is currently being fought in the US, with the government accusing a big pharma company of patent infringement for the first time.

News

Novartis will appeal Entresto patent setback

Novartis has suffered a defeat in its legal defence of chronic heart failure therapy Entresto, which accounted for around 11% of its revenues last year, but has vowed to t

News

SCOTUS won’t hear ‘skinny label’ lawsuit

The US Supreme Court has refused to look at the result of a federal lawsuit between GSK and Teva over so-called ‘skinny labels’ for generic drugs, despite a request from t

News

Relief for Amgen as it wins Otezla patent appeal

Amgen has won a crunch appeals court ruling that delays generic competition to its big-selling psoriasis drug Otezla in the US until 2028, although it missed out on gettin

R&D